Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| UGRO | Urban-gro | $36.30 | $29.28 | 417.09% | 70.7M | $5.3M | $2.02$36.30 |
| HSPTU | Horizon Space Acquisition II Corp. | $10.40 | $3.16 | 43.65% | 635 | $66M | $7.24$13.50 |
| PAYS | Paysign | $5.16 | $1.39 | 36.87% | 9.1M | $208M | $1.80$8.88 |
| SRPT | Sarepta Therapeutics | $23.75 | $6.14 | 34.87% | 635.7K | $1.8B | $10.42$74.40 |
| ARMG | Themes ETF Trust - Leverage Shares 2x Long Arm Daily ETF | $10.71 | $2.65 | 32.88% | 3.2M | - | $4.28$17.56 |
| VIVO | VivoPower International Plc | $2.84 | $0.68 | 31.48% | 3.3M | $36M | $1.20$8.88 |
| EEIQ | EpicQuest Education Group International | $2.92 | $0.69 | 30.94% | 165K | $3.3M | $1.90$27.84 |
| ROMA | Roma Green Finance | $10.25 | $2.41 | 30.74% | 939.8K | $467M | $0.72$11.77 |
| KSCP | Knightscope | $5.19 | $0.98 | 23.28% | 4.1M | $55M | $2.45$10.14 |
| CHNR | China Natural Resources | $5.35 | $0.95 | 21.59% | 168.4K | $5.4M | $3.16$8.20 |
| CVV | Cvd Equipment | $6.21 | $1.08 | 21.05% | 854K | $36M | $2.46$6.24 |
| BRZE | Braze | $21.78 | $3.76 | 20.87% | 447.2K | $2.0B | $15.26$43.89 |
| FEED | ENvue Medical | $2.72 | $0.46 | 20.35% | 21.5M | $2.5M | $0.99$162.50 |
| RKLX | Tidal Trust II - Defiance Daily Target 2x Long Rklb ETF | $34.13 | $5.65 | 19.84% | 4.4M | - | $3.32$78.00 |
| CORT | Corcept Therapeutics | $40.38 | $6.56 | 19.38% | 11.2M | $3.6B | $28.66$117.33 |
| SIDU | Sidus Space | $2.85 | $0.46 | 19.25% | 27.8M | $159M | $0.63$5.39 |
| EUDA | Euda Health | $10.84 | $1.71 | 18.73% | 14.8K | $345M | $6.42$86.00 |
| FBYD | Falcon's Beyond Global | $7.62 | $1.15 | 17.77% | 2.5K | $313M | $3.71$29.02 |
| RZLT | Rezolute | $3.16 | $0.47 | 17.47% | 12.2M | $257M | $1.07$11.46 |
| KJD | KraneShares Trust - KraneShares 2x Long Jd Daily ETF | $19.00 | $2.76 | 16.97% | 19.2K | - | $13.18$28.34 |
| QNRX | Quoin Pharmaceuticals | $9.33 | $1.33 | 16.57% | 4.1M | $4.7M | $5.01$41.80 |
| LWLG | Lightwave Logic | $8.56 | $1.21 | 16.39% | 265.6K | $1.1B | $0.79$8.79 |
| BZUN | Baozun | $2.47 | $0.34 | 15.73% | 22.5K | $114M | $2.11$4.88 |
| NIVF | NewGenIvf Group | $1.96 | $0.26 | 15.29% | 39.7K | $966K | $1.52$4,440.00 |
| SQFT | Presidio Property Trust | $2.54 | $0.33 | 14.93% | 16.9K | $3.2M | $2.10$23.00 |
| KRKR | 36Kr | $4.20 | $0.45 | 12.00% | 3.9K | $6.7M | $2.87$21.36 |
| BUUU | Buuu Group | $16.11 | $1.54 | 10.57% | 6.2K | $243M | $3.67$20.76 |
Related Articles
Featured Article
2 Beaten-Down Stocks That Could Sink Even More in 2026
Prosper Junior Bakiny|Jan 21, 2026
Don't catch a falling knife.
After a Big Win, Is Sarepta Therapeutics Stock a Buy?
Alex Carchidi|Jul 6, 2024
One key issue remains unresolved, and it could be a significant one.
Has Sarepta Therapeutics Become a No-Brainer Stock Buy After This Recent FDA News?
David Jagielski, CPA|Jul 4, 2024
The label expansion paves the way for much more revenue growth for Sarepta in the years ahead.
1 Soaring Growth Stock to Buy and Hold for 10 Years
Prosper Junior Bakiny|Jul 3, 2024
Let's look beyond the biotech's performance this year.
3 Stocks That Could Turn $1,000 Into $5,000 by 2030
Royston Yang|May 31, 2024
Investing in smaller, fast-growing companies will allow your portfolio to potentially jump ahead of the pack.
1 Top Growth Stock to Buy and Hold for 10 Years
Prosper Junior Bakiny|May 1, 2024
This company's lineup might look very different in a decade, but the end result will be the same for investors.
Braze Blazes Ahead
Motley Fool Staff|Apr 22, 2024
Braze co-founder and CEO Bill Magnuson helps us understand customer engagement.
Does This 1 New Threat Make Sarepta Therapeutics Stock Worth Selling?
Alex Carchidi|Mar 13, 2024
The threat is still emerging, but it could be significant.
Sarepta Therapeutics Stock Has 73% Upside, According to 1 Wall Street Analyst
Alex Carchidi|Mar 4, 2024
The upcoming regulatory decision on its latest drug could be big.
